These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1499595)

  • 21. Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended-Release Tablet Formulated With Abuse-Deterrence Technology.
    Darwish M; Yang R; Tracewell W; Robertson P; Bond M
    Clin Pharmacol Drug Dev; 2016 Mar; 5(2):141-9. PubMed ID: 27138027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
    van Harten J; Burggraaf J; van Brummelen P; Breimer DD
    Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic studies of nifedipine and digoxin co-administration.
    Koren G; Zylber-Katz E; Granit L; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate.
    Woodcock BG; Herrmann W; Habedank WD
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):63-5. PubMed ID: 1551748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked prolongation in disappearance half-time of plasma cholecystokinin-octapeptide in patients with hepatic cirrhosis.
    Kanayama S; Himeno S; Kurokawa M; Shinomura Y; Kuroshima T; Okuno M; Tsuji K; Higashimoto Y; Ikei N; Hashimura E
    Am J Gastroenterol; 1985 Jul; 80(7):557-60. PubMed ID: 4014106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical vasoactive cream in the treatment of erectile failure: a prospective, randomized placebo-controlled trial.
    Le Roux PJ; Naude JH
    BJU Int; 1999 May; 83(7):810-1. PubMed ID: 10368202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone pharmacokinetics in patients with cirrhosis.
    Dalhoff K; Poulsen HE; Garred P; Placchi M; Gammans RE; Mayol RF; Pfeffer M
    Br J Clin Pharmacol; 1987 Oct; 24(4):547-50. PubMed ID: 3689635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor agent in animal model and in patients with impaired renal function.
    Ikeda M; Furukawa H; Imamura H; Shimizu J; Ishida H; Masutani S; Tatsuta M; Kawasaki T; Satomi T
    Cancer Chemother Pharmacol; 2002 Jul; 50(1):25-32. PubMed ID: 12111108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver: role of kidneys and liver in pancreatic polypeptide metabolism.
    Boden G; Master RW; Owen OE; Rudnick MR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):573-8. PubMed ID: 7410534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of a single dose combination of nifedipine/acebutolol in patients with chronic liver disease.
    Lejeune P; Desager JP; Meunier H; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Oct; 26(10):513-6. PubMed ID: 3235218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mild and moderate hepatic impairment on the pharmacokinetics and safety of carisbamate.
    Moore K; Zannikos P; Solanki B; Greenspan A; Verhaeghe T; Brashear HR
    J Clin Pharmacol; 2012 May; 52(5):738-46. PubMed ID: 21566203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digitoxin in patients with hepatorenal insufficiency after repeated oral administration.
    Kirch W; Ohnhaus EE; Pabst J; Storstein L
    Eur Heart J; 1989 Jan; 10(1):40-7. PubMed ID: 2702965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic differences in the pharmacokinetics of oral nifedipine.
    Ahsan CH; Renwick AG; Macklin B; Challenor VF; Waller DG; George CF
    Br J Clin Pharmacol; 1991 Apr; 31(4):399-403. PubMed ID: 2049247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ciprofloxacin in liver cirrhosis.
    Ruhnke M; Trautmann M; Borner K; Hopfenmüller W
    Chemotherapy; 1990; 36(6):385-91. PubMed ID: 2292201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of turmeric extract on the pharmacokinetics of nifedipine after a single oral administration in healthy volunteers.
    Ikehata M; Ohnishi N; Egami S; Kishi H; Shin Y; Takara K; Tsuchishita Y; Tokuda N; Hori S; Yatani Y; Fujimura Y; Kusumoto M; Tatami R; Yoshioka M; Kuroda K; Yamada S; Yokoyama T
    J Diet Suppl; 2008; 5(4):401-10. PubMed ID: 22436099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of rosiglitazone in patients with end-stage renal disease.
    Thompson-Culkin K; Zussman B; Miller AK; Freed MI
    J Int Med Res; 2002; 30(4):391-9. PubMed ID: 12235921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of bioequivalence of a new fixed-dose combination of nifedipine and candesartan with the corresponding loose combination as well as the drug-drug interaction potential between both drugs under fasting conditions.
    Brendel E; Weimann B; Dietrich H; Froede C; Thomas D
    Int J Clin Pharmacol Ther; 2013 Sep; 51(9):753-62. PubMed ID: 23849325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.